Skip to main content

Table 2 Summary of drug interactions a

From: Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis

 

IC50-Based

LD50-Based

Combination

HB3 (CQS)

Dd2 (CQR)

HB3 (CQS)

Dd2 (CQR)

CQ-PQ

Antagonistic

Additive

Antagonistic

Antagonistic

CQ-TQ

Antagonistic

Antagonistic

-

-

CQ-AQ

Additive

Additive

Additive

Antagonistic

CQ-MB

Antagonistic

Antagonistic

-

-

AQ-PQ

Antagonistic

Antagonistic

-

-

AQ-TQ

Additive

Antagonistic

-

-

AQ-MB

Antagonistic

Antagonistic

-

-

PQ-MB

Antagonistic

Additive

-

-

TQ-MB

Additive

Synergistic

Synergistic

Synergistic

  1. aAntagonism is defined by a convex isobologram curve (FICindex > 1), additivity by a isobologram curve along the diagonal (FICindex = 1), and synergy by a concave isobologram curve (FICindex < 1) (Figure 2).